Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Du Yi Wei patch is a topical herbal formulation containing the extract of *Lamiophlomis rotata* (Kudo) Maxim, a perennial herb native to the Tibetan Plateau. Developed by Gansu Duyiwei Biological Pharmaceutical, this patch is utilized in Traditional Chinese Medicine (TCM) for its analgesic, anti-inflammatory, and hemostatic properties. It is specifically indicated for the treatment of acute limb soft tissue injuries associated with blood stasis syndrome, where it aims to promote blood circulation and reduce swelling and pain. The patch formulation offers a localized delivery method as an alternative to the established oral Du Yi Wei capsules, providing a transdermal route for the herb's active constituents, which include flavonoids, iridoids, and phenylethanoid glycosides.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Du Yi Wei patch.